Could AF Ablation have a "Placebo" Effect?
A small study raises big questions about patients' perceptions of AF symptoms after pulmonary vein ablation. What do you think?
Subclinical Atrial Fibrillation Rears its Head, Again
Increased detection of subclinical atrial fibrillation intensifies a common clinical quandary in AF patients: to anticoagulate, or not?
Hydroxychloroquine for Lupus Thins Thrombosis Risk
Long-term use of HCQ and low dose aspirin may work to reduce cardiovascular events.
More Doubt Cast on CPAP for Reducing CVD Risk in Sleep Apnea Patients
Some find new meta-analysis results disturbing; others say they underscore the need for more focused research.
Lupus Increases Cardiovascular Risk
Greater vigilance in monitoring for these outcomes and their modifiable risk factors is recommended.
Heart Disease in Lupus More Common than Previously Thought
EULAR 2017: Although already known to be highly prevalent, this test reveals that cardiovascular events are even more widespread in lupus.
Poor Sleep May Hike Mortality in Metabolic Syndrome
In the context of metabolic syndrome, sleep is thought to be an added and modifiable risk factor.
Which is safer? Celecoxib? Naproxen? Ibuprofen?
The long-awaited results from the PRECISION trial are in — with some caveats. In this slideshow, we summarize the results.
By clicking Accept, you agree to become a member of the UBM Medica Community.